Please join us for the HPS Corporate Lending Fund First Quarter 2026 Shareholder Update Webcast

Portfolio

HLEND seeks to build a diversified portfolio of senior secured private credit investments in resilient, market-leading, upper-middle market companies that operate primarily in non-cyclical sectors.

Data as of March 31, 2026

$25.0B

Investments at Fair Value

9.3%

Portfolio Yield at Fair Value1

94%

Private Investments2

95%

First Lien Exposure3

99%

Floating Rate4

$255M

Weighted Average EBITDA5

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread11
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
Omega II AB (Fortnox AB) Software ST + 4.25% SEK 943,460 97,195 100,684 0.40%
OneDigital Borrower LLC (OneDigital) Insurance S + 3.00% $14,625 14,575 14,177 0.06%
OneTeam Partners, LLC (OneTeam Partners) Media 8.00% $947 947 1,241 0.00%
Orthrus Ltd (Ocorian) Financial Services S + 6.25% (incl 2.75% PIK) $95,971 94,647 94,834 0.38%
Orthrus Ltd (Ocorian) Financial Services SN + 6.25% (incl 2.75% PIK) £42,666 44,599 46,335 0.19%
Orthrus Ltd (Ocorian) Financial Services E + 6.25% (incl 2.75% PIK) €31,733 33,224 36,249 0.14%
Osaic Holdings Inc (Advisor Group Holdings, Inc) Financial Services S + 2.50% $15,160 15,125 14,905 0.06%
PCP CW Aggregator Holdings II, L.P. (CardWorks, Inc.) Consumer Finance S + 6.75% $21,909 21,856 21,947 0.09%
PEX Holdings LLC (Gen II Fund Services, LLC) Financial Services S + 2.75% $14,850 14,820 14,720 0.06%
PF Finco PTY LTD (Hunter Premium Funding) Financial Services B + 6.25% AUD 47,560 26,402 28,399 0.11%
PPV Intermediate Holdings, LLC (VetCor) Health Care Providers & Services S + 5.75% $24,198 22,124 22,047 0.09%
PTSH Intermediate Holdings, LLC (PT Solutions) Health Care Providers & Services S + 5.00% $10,106 9,940 9,949 0.04%
Palmetto TE Borrower LLC Independent Power and Renewable Electricity Producers S + 5.50% $172,374 170,390 170,618 0.68%
Pareto Health Intermediate Holdings, Inc. Health Care Providers & Services S + 5.00% $88,163 83,009 83,254 0.33%
Parexel International, Inc. (Parexel) Health Care Providers & Services S + 2.75% $16,548 16,456 16,514 0.07%
Parfums Holding Company, Inc. (PDC Wellness) Personal Care Products S + 5.25% $124,259 114,352 115,225 0.46%
PerkinElmer U.S. LLC (PerkinElmer) Life Sciences Tools & Services S + 4.75% $275,142 271,759 274,088 1.10%
PetSmart LLC (PetSmart, Inc.) Specialty Retail S + 4.00% $16,738 16,585 16,658 0.07%
Phantom Purchaser Inc (Pharmacord LLC) Life Sciences Tools & Services S + 4.75% $115,837 99,291 99,733 0.40%
Pike Corporation (Pike Corp) Construction & Engineering S + 4.50% $164,001 118,222 117,278 0.47%
Pinnacle Fertility, Inc. (Pinnacle Fertility) Health Care Providers & Services S + 5.00% $35,447 35,213 35,447 0.14%
Planet US Buyer LLC (Wood Mackenzie, Inc.) Professional Services S + 3.00% $7,369 7,356 7,380 0.03%
Plasma Buyer LLC (Path Group Inc.) Health Care Providers & Services S + 5.75% PIK $99,193 91,271 55,423 0.22%
Plasma Buyer LLC (Path Group Inc.) Health Care Providers & Services S + 6.25% PIK $9,730 4,905 3,829 0.02%
Precision Medicine Group, LLC Health Care Providers & Services S + 3.50% $7,960 7,924 7,959 0.03%

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of March 31, 2026.
  4. Percentage based on aggregate fair value of accruing debt.
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on MSCI / S&P Global Industry Classification Standard (“GICS”) industry definition. Totals may not sum due to rounding. 
  9. All figures are as of March 31, 2026 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.
  11. Contractual rates on preferred equity investments may represent preference accruals that are not recognized through investment income of the fund and as such are not included in the calculation of yield. The fair value of these investments may be influenced by the stated preference accrual or a minimum return threshold.